Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
Key takeaways of recent quarter & conference call highlights
Key takeaways of recent quarter & conference call highlights
Invisible Nation is a worldwide network of patient organizations committed to driving a decline in cardiovascular (CV) death by effecting systemic change in atherosclerotic cardiovascular disease (ASCVD) care
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
It recommends using the vaccine to prevent the spread of the disease
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20
This product will be manufactured at Lupin’s Pithampur facility In India
According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021
Subscribe To Our Newsletter & Stay Updated
